There was no significant difference in IRF8 expression between triple-negative breast cancers (TNBCs) (n = 379) and non-TNBCs (n = 42) in the 2015 TCGA breast cancer database (p > 0.05) (Figure 1B). Here, IRF8 is linked to breast carcinoma.